FP-045

· Foresee Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FP-045, covering 2025-03-06 to 2025-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia [Phase 1, Phase 2]